Statistically, the prevalence of heart failure increases with age, but a new prospective study is validating what holistic physicians have known for years: that a healthy lifestyle can markedly reduce the risk.
A new study
shows that tocotrienols, an important component of naturally occurring Vitamin E, can prevent neural damage following ischemic stroke, potentially improving post-stroke outcomes.
Folic acid supplementation before and during pregnancy is widely recommended for preventing neural tube defects. New data indicate that it can also reduce the risk of cleft lip and congenital heart defects. At the other end of the age spectrum, folic acid in combination with vitamins B6 and B12 can reduce a woman’s risk of age-related macular degeneration.
Clinical research on CoQ10 continues to point toward new uses including blood pressure reduction, glycemic control and potentially reducing risk of neurodegenration. CoQ10 in its reduced form, known as ubiquinol, often improves outcomes in conditions like as severe heart failure, when the more common ubiquinone form, has proven ineffective.
Hibiscus, a popular tea herb in many parts of the world, can markedly lower systolic blood pressure in type II diabetic people with mild hypertension, according to a recent clinical trial. On the other hand, black tea tends to increase systolic pressure.
Central Aortic Systolic Pressure (CASP) is one of the most powerful early predictors of cardiovascular risk. New digital pulse wave analysis technology is putting this valuable test in the hands of preventive primary care doctors.
Sleep apnea is common, debilitating and sometimes deadly. In the past, diagnosis involved costly sleep labs. New home monitoring devices provide greater patient comfort, save money, and generate revenue for primary care. Dr. Lee Surkin shares his clinical experience.
Gaseous Surface of Jupiter: Many cardiologists are hailing the massive JUPITER trial as a breakthrough, claiming that statin therapy could reduce cardiovascular risk even in patients with normal LDL.
Cutting edge early risk detection tests and preventive medicine have become the privilege of the wealthy. Dr. James Ehrlich, a pioneer in cardiovascular risk assessment, hopes to change that with his new Identify Disease in Advance Foundation, which will bring state-of-the-art preventive medicine to people who can least afford it but would most benefit from it.
Gamma glutamyl transferase (GGT) is a hepatic enzyme that indicates levels of oxidative stress in the liver. A large body of research suggests that it can also predict onset of insulin resistance, type 2 diabetes, and cardiovascular disease. At under $10 per test, it could be a very valuable asset in clinical practice.
Copyright © 2021 Holistic Primary Care. All Rights Reserved.
